NCT01206582View on ClinicalTrials.gov

A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
GastroparesisDiabetes Mellitus
Interventions
BIOLOGICAL

Hemin

10 iv infusions for 8 weeks

BIOLOGICAL

Albumin

10 iv infusions for 8 weeks

Trial Locations (1)

55901

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Recordati Rare Diseases

INDUSTRY

lead

Mayo Clinic

OTHER